Faricimab helped improve vision in previously untreated patients with neovascular age-related macular degeneration, according to a real-world study presented at Retina 2025. Ferhina S. Ali, MD, MPH, ...

A multidisciplinary team of researchers from the Istituto Italiano di Tecnologia (IIT-Italian Institute of Technology) and ...

A multidisciplinary team of researchers from the Istituto Italiano di Tecnologia (IIT-Italian Institute of Technology) and ...

University of California San Diego researchers have identified a U-shaped association between high-density lipoprotein (HDL) ...

Age-related macular degeneration (AMD), which affects about 200 million people worldwide and can result in legal blindness, impairs an area of the eye (retina) used for reading, driving and many other ...

Age related macular degeneration is one of the most frequently occurring reasons for decreased vision in the elderly population in Western countries. 1 It is divided in a non-exudative form with ...

The RCT TALON, which compares brolucizumab and aflibercept for the treatment of neovascular (wet) age-related macular degeneration, shows that there is another way. In the TALON study, a treat-and ...

Abstract: Age-related macular degeneration (AMD) is a leading cause of vision loss ... revealing hidden features of AMD that are not visible to the human eye. Future research will focus on improving ...

Age-related macular degeneration (AMD ... injections and limited effectiveness in restoring vision. The research team led by Dr. Moon-Hyeong Seo from the Natural Product Drug Development Center ...

Age-related macular degeneration (AMD ... from intravitreal injections and modest efficacy in restoring vision. The research team led by Dr. Moon-Hyeong Seo from the Natural Product Drug ...